Tina Wang

Tina Wang is the Director of the HTA Programme and Strategic Partnerships at the Centre for Innovation in Regulatory Science (CIRS), an international think tank dedicated to advancing regulatory and HTA policies and practices worldwide. Tina leads CIRS’ global work on HTA strategy and research, driving initiatives that inform evidence-based policy development and foster alignment across regulatory and HTA systems. She oversees the conceptualisation, design, and delivery of HTA-related projects, ensuring that CIRS’ research agenda reflects the evolving needs of the global HTA landscape. With extensive experience working in complex, multi-stakeholder environments, Tina builds and manages strategic partnerships with regulatory agencies, HTA bodies, industry, academia, and patient groups. Her work focuses on facilitating policy dialogue, advancing best practices, and strengthening global collaboration to support efficient, transparent, and patient-centred HTA decision making.